Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common stock
-
Shares outstanding
-
47.1M
-
Number of holders
-
50
-
Total 13F shares, excl. options
-
12.5M
-
Shares change
-
-144K
-
Total reported value, excl. options
-
$213M
-
Value change
-
-$7.7M
-
Number of buys
-
28
-
Number of sells
-
-15
-
Price
-
$16.97
Significant Holders of Whitehawk Therapeutics, Inc. - Common stock (WHWK) as of Q1 2022
59 filings reported holding WHWK - Whitehawk Therapeutics, Inc. - Common stock as of Q1 2022.
Whitehawk Therapeutics, Inc. - Common stock (WHWK) has 50 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.5M shares
of 47.1M outstanding shares and own 26.6% of the company stock.
Largest 10 shareholders include Avoro Capital Advisors LLC (1.83M shares), ACUTA CAPITAL PARTNERS, LLC (1.53M shares), VR Adviser, LLC (1.53M shares), BVF INC/IL (879K shares), Vivo Capital, LLC (772K shares), RTW INVESTMENTS, LP (765K shares), VANGUARD GROUP INC (760K shares), STATE STREET CORP (536K shares), Decheng Capital Management III (Cayman), LLC (526K shares), and PRICE T ROWE ASSOCIATES INC /MD/ (436K shares).
This table shows the top 50 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.